Mirum Pharmaceuticals, Inc. (MIRM) Operating income 2019–2025
Mirum Pharmaceuticals, Inc. (MIRM) annual operating income history from SEC filings — each fiscal year as reported.
-$22.1MFY2025 · since FY2019: -$54.7M → -$22.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.1M | +74.7% |
| FY2024 | -$87.6M | +19.7% |
| FY2023 | -$109.2M | +16.8% |
| FY2022 | -$131.2M | +24.3% |
| FY2021 | -$173.4M | -66.3% |
| FY2020 | -$104.3M | -90.5% |
| FY2019 | -$54.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice